Orgenesis Inc. Change in inventories

Change in inventories of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in inventories growth rates and interactive chart.


Highlights and Quick Summary

  • Change in inventories for the quarter ending September 29, 2021 was $34 Thousand (a 25.93% increase compared to previous quarter)
  • Year-over-year quarterly Change in inventories increased by 183.33%
  • Annual Change in inventories for 2020 was $-84 Thousand (a -79.71% decrease from previous year)
  • Annual Change in inventories for 2019 was $-414 Thousand (a -55.53% decrease from previous year)
  • Annual Change in inventories for 2018 was $-931 Thousand (a -0.0% decrease from previous year)
  • Twelve month Change in inventories ending September 29, 2021 was $53 Thousand (a 15.22% increase compared to previous quarter)
  • Twelve month trailing Change in inventories decreased by -163.1% year-over-year
Trailing Change in inventories for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$53 Thousand $46 Thousand $-28 Thousand $-84 Thousand
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in inventories of Orgenesis Inc.

Most recent Change in inventoriesof ORGS including historical data for past 10 years.

Interactive Chart of Change in inventories of Orgenesis Inc.

Orgenesis Inc. Change in inventories for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.03 $0.03 $-0.02
2020 $0.01 $0.03 $-0.05 $-0.08 $-0.08
2019 $-0.12 $0.28 $-0.21 $-0.37 $-0.41
2018 $0.01 $-0.32 $-0.4 $-0.13 $-0.93
2017 $-0.02 $-0.25 $-0.22 $-0.27
2016 $0.02 $-0.09 $-0.1
2015 $-0.09

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.